Outcome of Board Meeting held on 29th May, 2026 for Consideration and Approval Audited Financial Result for the Quarter and Year ended 31st March, 2026 and other matters
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zenith Healthcare Ltd's Board approved audited financial results for Q4 and FY ended March 2026. Profit before tax declined sharply to Rs. 1.60 Lakhs from Rs. 27.92 Lakhs in the previous year—a 94% drop. Total income stood at approximately Rs. 271.83 Lakhs for Q4. Operating cash flow turned negative at Rs. 83.40 Lakhs compared to positive Rs. 55.44 Lakhs in FY2025, primarily due to significant increases in inventories (Rs. 65.38 Lakhs) and other current assets (Rs. 81.69 Lakhs). The Board also appointed Mr. Akshit Mahendra Raycha (son of CMD) as Joint Managing Director for 3 years with remuneration up to Rs. 2 Lakhs/month (increased by Rs. 9 Lakhs annually). Multiple related party transactions with Ray Remedies Pvt Ltd, Raxin Healthcare, Achyut Healthcare, and family members were reviewed. Statutory auditors Doshi Doshi & Co issued an unmodified (clean) opinion. Internal auditors Mohta Khetawat & Co were also appointed for FY2026-27.
The stock may face pressure due to steep profit decline and negative operating cash flow, indicating working capital stress. However, clean audit opinion and new leadership appointment provide some stability. Related party transactions with family entities warrant shareholder attention.